Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
3481 results about "Triglyceride" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
A triglyceride (TG, triacylglycerol, TAG, or triacylglyceride) is an ester derived from glycerol and three fatty acids (from tri- and glyceride). Triglycerides are the main constituents of body fat in humans and other vertebrates, as well as vegetable fat. They are also present in the blood to enable the bidirectional transference of adipose fat and blood glucose from the liver, and are a major component of human skin oils.
4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
Cholesteryl ester transfer protein inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and / or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases in some mammals, including humans.
Owner:PFIZER INC
4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines
Cholesteryl ester transfer protein inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and / or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases in some mammals, including humans.
Owner:PFIZER INC
Pharmaceutical compositions for lipophilic drugs
InactiveUS7070802B1Good self-emulsifying performanceShelf-stableCyclic peptide ingredientsCapsule deliveryMonoglycerideCyclosporins
Stable solutions of lipophilic drugs, such as cyclosporin, forming a polar lipid self-emulsifying drug delivery system. The solutions can include lipophilic drugs, such as cyclosporin, dissolved in a polar lipid, such as having a C6-C12 fatty acid monoglyceride content of at least about 50%, surfactants and triglycerides. The composition forms a fine emulsion on exposure to water. The encapsulated dosage form of this composition needs neither a hydrophilic component nor air-tight blister packaging, and is particularly suitable for oral administration.
Owner:WATSON LAB INC
Pharmaceutical combinations for lipid management and in the treatment of atherosclerosis and hepatic steatosis
A pharmaceutical combination comprising an effective amount of at least one cholesterol absorption inhibitor and at least one microsomal triglyceride transfer protein inhibitor (MTP).
Owner:SCHERING CORP
Analyte test system for determining the concentration of an analyte in a physiological or aqueous fluid
InactiveUS20050196747A1Cheap productionReliable resultsBioreactor/fermenter combinationsBiological substance pretreatmentsSmall sampleQuality control system
This invention provides a device for determining the concentration of an analyte like glucose, cholesterol, free fatty acids, triglycerides, proteins, ketones, phenylalanine or enzymes, in a physiological or aqueous fluid like blood, serum, plasma, saliva, urine, interstitial and / or intra-cellular fluid, the device having an integrated calibration and quality control system suitable for dry reagent test strips with a very small sample volume of about 0.5 μL based on to a new sample distribution system. The production of the inventive analyte test element involves only a small number of uncomplicated production steps enabling an inexpensive production of the strips.
Owner:EGOMEDICAL SWISS
Fuel Composition
ActiveUS20080229654A1Maximize product yieldYield maximizationFatty acid isomerisationFatty acid oxidationIsomerizationVegetable oil
Compositions and methods for forming hydrocarbon products from triglycerides are disclosed. In one aspect, the methods involve the thermal decomposition of fatty acids, which can be derived from the hydrolysis of triglycerides. The thermal decomposition products can be combined with low molecular weight olefins, such as Fischer-Tropsch synthesis products, and subjected to molecular averaging reactions. Alternatively, the products can be subjected to hydrocracking reactions, isomerization reactions, and the like. The products can be isolated in the gasoline, jet and / or diesel fuel ranges. Thus, vegetable oils and / or animal fats can be converted using water, catalysts, and heat, into conventional products in the gasoline, jet and / or diesel fuel ranges. These products are virtually indistinguishable from those derived from their petroleum-based analogs, except that they can have virtually no aromatic, sulfur or nitrogen content, they are derived, in whole or in part, from renewable resources, and can also be derived from domestically available coal and / or natural gas.
Owner:BRADIN DAVID
Hyperlipemia therapeutic agent
The present invention relates to a hyperlipemia therapeutic agent comprising pitavastatins and eicosapentaenoic acid or an ester derivative thereof as effective ingredients.According to the present invention, a type IIb and type IV hyperlipemia therapeutic agent having an excellent effect of lowering the cholesterol and triglyceride in blood is provided.
Owner:KOWA CO LTD +1
Annulated 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines
Cholesteryl ester transfer protein inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and / or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases in some mammals, including humans.
Owner:PFIZER INC
Hyperlipemia therapeutic agent
The present invention relates to a hyperlipemia therapeutic agent comprising pitavastatins and eicosapentaenoic acid or an ester derivative thereof as effective ingredients. According to the present invention, a type IIb and type IV hyperlipemia therapeutic agent having an excellent effect of lowering the cholesterol and triglyceride in blood is provided.
Owner:KOWA CO LTD +1
Vegetable oil candle
InactiveUS6730137B2Novel burning and fragrance characteristicBiofuelsSolid fuelsParaffin waxVegetable oil
A candle composition has a paraffin wax mixture of a high melting point paraffin wax and a low melting point paraffin wax, and a hydrogenated vegetable oil that is present in a greater amount than the mixture of the varying grades of paraffin wax, and the vegetable oil contains no more than 0.15% free fatty acid, with the remainder being triglycerides. Candles of the composition have good burn characteristics, particularly good fragrance intensity and produce a unique crystallization effect after the first burn.
Owner:BEAUTYAVENUES
Process for producing biodiesel fuel using triglyceride-rich oleagineous seed directly in a transesterification reaction in the presence of an alkaline alkoxide catalyst
InactiveUS7112229B2Fatty oils/acids recovery from wasteFatty acid esterificationOil and greaseBiodiesel
An integrated process is described for producing biodiesel from oleaginous seeds, preferably castor bean seeds. The inventive process includes a transesterification reaction where the seeds themselves react with anhydrous ethyl alcohol in the presence of an alkaline catalyst. The resulting ethyl esters are then separated by decantation and neutralized and used as fuel for diesel engines, co-solvents for diesel and gasoline mixtures with anhydrous or hydrated ethyl alcohol. The solid fractions may be used as fertilizers, for feeding cattle and as a raw material for producing ethyl alcohol.
Owner:PETROLEO BRASILEIRO SA (PETROBRAS)
Edible Oil and Processes for Its Production from Microalgae
InactiveUS20100303957A1Simple preparation conditionsFatty acid hydrogenationReady-for-oven doughsCelluloseBiotechnology
Novel triglyceride oils are provided for human consumption. Traditionally, agricultural materials such as canola, soybean, and olives have been the sources of edible oils, and such materials are limited by the geography in which these crops can be cultivated. Oils of the invention can be manufactured from edible and inedible heterotrophic fermentation feedstocks, including corn starch, sugar cane, glycerol, and depolymerized cellulose that are purpose-grown or byproducts of existing agricultural processes from an extremely broad diversity of geographic regions. The food oils disclosed herein are low in saturates, high in monounsaturates, and can be manufactured in reduced pigment form through the use of pigment-reduced microalgae strains. The food oils disclosed herein can be manufactured through the use of a variety of different types of oil-producing microalgae.
Owner:TERRAVIA HLDG INC
Methods of Inducing Satiety
InactiveUS20100303961A1Increase satietyImprove the level ofMilk preparationSpread compositionsFiberDietary fiber
Disclosed herein are methods of inducing satiety by providing microalgae-based foods. In some embodiments, microalgal biomass contains high levels of dietary fiber and / or digestible crude protein and / or low saturation triglyceride oil. Homogenization methods to liberate free oil and fiber are disclosed for enhancing the feeling of satiety in a human, thereby reducing caloric intake. The provision of such materials to a human have the further benefit of providing heart-healthy microalgae-based ingredients while achieving levels of satiety sufficient to reduce further caloric intake.
Owner:TERRAVIA HLDG INC
4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines
Cholesteryl ester transfer protein inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and / or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases in some mammals, including humans.
Owner:PFIZER INC
Melting Vegetable Protein Based Substitute Cheese
This invention is directed to a molded, pressed, low animal fat substitute cheese composition, comprising;moisture in an amount that is at least about 50% by weight of the cheese composition, and(A) a vegetable protein material;(B) a vegetable oil triglyceride; and(C) a hydrocolloid.In another embodiment, the molded, pressed, low animal fat substitute cheese compositions further comprises at least one component selected from the group consisting of(D) a cheese flavorant and(E) a starch.
Owner:SOLAE LLC
Annulated 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
Cholesteryl ester transfer protein inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and / or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases in some mammals, including humans.
Owner:PFIZER INC
Fat accumulation-modulation compounds
InactiveUS20030144350A1Decreasing level of acid and triglyceride accumulationReducing weight gainBiocideMetabolism disorderDrugLine of therapy
The present invention pertains to compounds effective at modulating fatty acid or triglyceride ("fat") accumulation by cells, such compounds having therapeutic potential as regulators of body mass and for the treatment of overweight individuals, obesity, and metabolic disorders. Featured compounds are set forth and exemplified herein. Therapeutic methods and pharmaceutical compositions featuring these compounds are also provided.
Owner:ADIPOGENIX
Production and Purification of Esters of Polyunsaturated Fatty Acids
The present invention includes methods for producing and purifying esters of polyunsaturated fatty acids that include reacting a composition having triglycerides with polyunsaturated fatty acid residues in the presence of an alcohol and a base to produce an ester of a polyunsaturated fatty acid from the triglycerides. The composition can be a polyunsaturated fatty acid-containing composition that has not been conventionally processed. The reacted composition can be further processed by distillation.
Owner:DSM IP ASSETS BV
4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
Owner:PFIZER INC
Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
Cholesteryl ester transfer protein inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and / or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases in some mammals, including humans.
Owner:PFIZER INC
Vegetable oil candle
InactiveUS20030091949A1Novel burning and fragrance characteristicBiofuelsSolid fuelsParaffin waxVegetable oil
A candle composition has a paraffin wax mixture of a high melting point paraffin wax and a low melting point paraffin wax, and a hydrogenated vegetable oil that is present in a greater amount than the mixture of the varying grades of paraffin wax, and the vegetable oil contains no more than 0.15% free fatty acid, with the remainder being triglycerides. Candles of the composition have good burn characteristics, particularly good fragrance intensity and produce a unique crystallization effect after the first burn.
Owner:BEAUTYAVENUES
Ophthalmic devices for delivery of hydrophobic comfort agents
ActiveUS20100140114A1Easy to understandPackage sterilisationPharmaceutical delivery mechanismLipid formationMonoglyceride
The invention relates to a soft hydrogel contact lens, especially a silicone hydrogel contact lens, which has a capability of delivering a hydrophobic comfort agent into the eye of a wearer. The hydrophobic comfort agent includes without limitation a monoglyceride, a diglyceride, a triglyceride, a glycolipid, a glyceroglycolipid, a sphingolipid, a sphingo-glycolipid, a phospholipid, a fatty acid, a fatty alcohol, a hydrocarbon having a C12-C28 chain in length, a mineral oil, a silicone oil, or a mixture thereof. It can be released from the soft hydrogel contact lens into the eye of a wearer when being worn so as to strengthen and stabilize the tear film lipid layer and alleviate the dryness of the eye.
Owner:ALCON INC
A kind of infant formula milk powder that does not get angry and its preparation process
ActiveCN102283289ANot ediblePromote digestion and absorptionMilk preparationVegetable oilFructooligosaccharide
The invention relates to an anti-inflaming infant formula milk powder and a preparation process thereof. The anti-inflaming infant formula milk powder comprises the following components in percentage by weight: 22%-50% of lactose, 10%-20% of goat milk whey protein concentrate, 9.8%-20% of structural grease 1,3-dioleoyl 2-palmitoyl triglyceride, 10%-13.5% of non-fat goat milk powder, 8%-10% of vegetable oil, 2%-8% of beta-casein, 0.8%-1.6% of fructooligosaccharides, 0.5%-1.5% of mineral premix, 0.3%-1% of galactooligosaccharide, 0.2%-1% of immunoglobulin G, 0.2%-0.5% of lactulose, 0.10%-0.45% of arachidonic acid, 0.1%-0.6% of docosahexaenoic acid, 0.06%-0.12% of vitamin premix, 0.04%-0.06% of lactoferrin, and 0.01%-0.06% of nucleotide. The invention also includes the preparation process ofthe infant formula milk powder. The nutrition constituents and the functions of the infant formula milk powder are close to those of breast milk, the infant formula milk powder is easy to assimilate,and infants do not get inflamed after eating the milk powder.
Owner:AUSNUTRIA DAIRY CHINA
Method of producing fatty acid lower alkylester from fat and oil
InactiveUS6090959AImprove reaction efficiencySimplify eliminate needFatty acid esterificationFatty acids production/refiningAlcoholTransesterification
In a method of producing a fatty acid lower alkylester according to the invention, a fat & oil and a lower alcohol are caused to react with each other in the presence of a catalyst, in which triglyceride contained in the fat & oil undergoes a transesterification. The catalyst to be used in the reaction is a solid basic catalyst consisting essentially of a potassium compound and iron oxide, of a calcium compound and iron oxide, or of a potassium compound and zirconium oxide. It is possible to produce the fatty acid lower alkylester at a high reaction efficiency by this method as well as to simplify or eliminate the need of catalyst separation and recovery processes.
Owner:GREENTECH SOLUTION
Process for the preparation of fatty acid methyl ester from triglyceride oil by transesterification
InactiveUS20060080891A1Produced cost-effectivelyReduce water contentFatty oils/acids recovery from wasteFatty acid esterificationTransesterificationUnit operation
The present invention relates to an improved process for the preparation of biodiesel from triglyceride oils through transesterification, particularly the fatty acid methyl ester of oil mechanically expelled from whole seeds of Jatropha curcas, a plant with potential for cultivation on wastelands in India and other countries, all unit operations being carried out at ambient temperature.
Owner:COUNCIL OF SCI & IND RES
Soy protein containing food product and process for preparing same
This invention relates to a soy protein containing food product comprising; (A) a soy protein material selected from the group consisting of a soy protein flour, a soy protein concentrate, a soy protein isolate and mixtures thereof; (B) a humectant comprising (i) a colorant and at least one selected from the group consisting of (ii) a flavoring agent, (iii) a triglyceride, (iv) a food grade acid or acidic salt, (v) a food grade base or basic salt, and (vi) a food grade emulsion; and (C) water. In another embodiment, the invention is directed to a process for preparing a soy protein containing food product.
Owner:SOLAE LLC
Process for producing a renewable fuel in the gasoline or jet fuel range
ActiveUS7928273B2Yield maximizationFatty acid isomerisationFatty acid oxidationVegetable oilGasoline
Processes for producing hydrocarbons in the gasoline and jet fuel range. The processes involve the thermal decarboxylation of fatty acids, which can be derived from the hydrolysis of triglycerides, which triglycerides can be vegetable oils, animal fats, or combinations thereof. The resulting hydrocarbons can be hydrocracked, and, optionally, isomerized and / or hydrotreated, to yield hydrocarbons in the jet fuel or gasoline range. Where the resulting hydrocarbons include olefinic double bonds, they can alternatively be combined with low molecular weight olefins, and subjected to olefin metathesis to yield hydrocarbons in the jet fuel or gasoline range.
Owner:BRADIN DAVID
Dietary supplements and prepared foods containing triglyceride-recrystallized non-esterified phytosterols
ActiveUS7575768B2Reduce fat oxidationReduce probabilityVitamin food ingredientsFatty substance preservation using additivesFood additiveDietary supplement
A nutritional supplement, prepared food product, or direct food additive for ingestion by mammals, and methods for preparing such products, are provided. Products of the invention comprise an oxidation-resistant fat-based composition substantially free of exogenous solubilizing and dispersing agents for phytosterols. The fat-based composition includes greater than 25% and less than 75% by weight of one or more triglyceride-based edible oil or fat, and greater than 25% and less than 75% by weight of one or more non-esterified phytosterols. The fat-based composition, when exposed to air, contains a reduced amount of oxidative by-products compared to a similar fat-based composition lacking non-esterified phytosterols. Also provided are methods for reducing plasma cholesterol in mammals, and methods for protecting plasma lipoproteins and cholesterol from oxidation by ingestion of products of the invention.
Owner:BRANDEIS UNIV
Processes for producing alkyl ester of fatty acid
InactiveUS6960672B2Fatty acid esterificationFatty acids production/refiningAlkaline earth metalFatty acid
The present invention relates to a process for preparing an alkyl ester of a fatty acid wherein a transesterification reaction is carried out between a fat or oil and an alcohol in the presence of a catalyst comprising a composite metal oxide having a perovskite structure; and a process for preparing an alkyl ester of a fatty acid wherein a transesterification reaction is carried out between a fat or oil and an alcohol in the presence of a catalyst comprising at least one member selected from the group consisting of oxides, hydroxides and carbonates of alkaline earth metals is used as the catalyst, with the alcohol made into a supercritical state or subcritical state. According to the present invention, the alkyl ester of a fatty acid which can be effectively utilized as a diesel fuel oil or the like can be prepared at high efficiency and on an industrial scale mainly from triglyceride contained in a fat or oil, especially a waste oil.
Owner:REBO INT
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com